CLIMARA (estradiol) by Bayer is estrogen receptor agonists [moa]. Approved for estrogen [epc]. First approved in 1994.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
CLIMARA is a transdermal extended-release film delivering estradiol, an estrogen receptor agonist used for hormone replacement therapy in menopausal women. It treats vasomotor symptoms (hot flashes, night sweats) and vulvovaginal atrophy by restoring systemic estrogen levels. The transdermal route provides steady-state hormone delivery while bypassing first-pass hepatic metabolism.
Mature product in late patent life with modest Medicare utilization; team focus shifting toward retention strategies and generic transition planning.
Estrogen Receptor Agonists
Estrogen
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)
A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together
A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants
Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)
Worked on CLIMARA at Bayer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moCLIMARA roles are primarily defensive and operational; teams focus on manufacturing efficiency, payer negotiations, and patient retention as generic entry looms. Career progression on this product is limited unless transitioned to broader franchise or LOE management roles.